Cardiovascular changes associated with venlafaxine in the treatment of late-life depression

Am J Geriatr Psychiatry. 2007 Aug;15(8):725; author reply 726. doi: 10.1097/JGP.0b013e3180488358.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Aged
  • Antidepressive Agents, Second-Generation / adverse effects*
  • Antidepressive Agents, Second-Generation / therapeutic use
  • Blood Pressure / drug effects*
  • Cyclohexanols / adverse effects*
  • Cyclohexanols / therapeutic use
  • Delayed-Action Preparations
  • Depressive Disorder / drug therapy*
  • Double-Blind Method
  • Electrocardiography / drug effects*
  • Female
  • Heart Rate / drug effects*
  • Humans
  • Male
  • Nortriptyline / adverse effects
  • Nortriptyline / therapeutic use
  • Randomized Controlled Trials as Topic
  • Venlafaxine Hydrochloride

Substances

  • Antidepressive Agents, Second-Generation
  • Cyclohexanols
  • Delayed-Action Preparations
  • Venlafaxine Hydrochloride
  • Nortriptyline